Article
Recent advances in asthma biomarker research.
Therapeutic advances in respiratory disease - 1 Oct 2013
Leung Ting F, Ko Fanny W S, Wong Gary W K
Abstract excerpt
Asthma is characterized by recurrent and reversible airflow obstruction, which is routinely monitored by history and physical examination, spirometry and home peak flow diaries. As airway inflammation is central to asthma pathogenesis, its monitoring should be part of patient management plans. Fractional exhaled nitric oxide level (FeNO) is the most extensively studied biomarker of airway inflammation, and FeNO...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
